{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Coronary+Insufficiency&page=4", "query": { "condition": "Chronic Coronary Insufficiency", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 159, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Coronary+Insufficiency&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Coronary+Insufficiency&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T09:22:26.170Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00497146", "title": "The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Kidney Disease", "Left Ventricular Hypertrophy" ], "interventions": [ { "name": "paricalcitol", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 227, "start_date": "2008-02", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2013-03-12", "last_synced_at": "2026-10-05T09:22:26.170Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Tempe, Arizona • San Diego, California + 24 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "San Dimas", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00497146" }, { "nct_id": "NCT04351880", "title": "Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Failure", "Copd", "Liver Failure", "Diabetes Mellitus", "Cancer", "End Stage Renal Disease" ], "interventions": [ { "name": "Medically Tailored Meals", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 650, "start_date": "2020-04-16", "completion_date": "2021-12-31", "has_results": false, "last_update_posted_date": "2022-02-17", "last_synced_at": "2026-10-05T09:22:26.170Z", "location_count": 2, "location_summary": "Denver, Colorado • Lafayette, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Lafayette", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04351880" }, { "nct_id": "NCT01855334", "title": "L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "End Stage Renal Disease", "Hemodialysis" ], "interventions": [ { "name": "Spironolactone", "type": "DRUG" }, { "name": "L-arginine", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 0, "start_date": "2013-09", "completion_date": "2018-07", "has_results": false, "last_update_posted_date": "2017-05-04", "last_synced_at": "2026-10-05T09:22:26.170Z", "location_count": 3, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01855334" }, { "nct_id": "NCT00863707", "title": "A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Kidney Diseases", "Coronary Artery Disease" ], "interventions": [ { "name": "Regadenoson", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 511, "start_date": "2009-04", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2012-05-18", "last_synced_at": "2026-10-05T09:22:26.170Z", "location_count": 41, "location_summary": "Anniston, Alabama • Little Rock, Arkansas • Bell Gardens, California + 36 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bell Gardens", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00863707" }, { "nct_id": "NCT05001009", "title": "Goals of Care Conversations Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Seriously Ill Patients", "Cancer", "Heart Failure", "Interstitial Lung Disease", "Chronic Obstructive Pulmonary Disease", "End-stage Renal Disease", "End-stage Liver Disease", "Dementia" ], "interventions": [ { "name": "Clinician Implementation Strategy Stage 1: low intensity clinician training", "type": "BEHAVIORAL" }, { "name": "Clinician Implementation Strategy Stage 2: high intensity clinician training", "type": "BEHAVIORAL" }, { "name": "Low patient engagement", "type": "BEHAVIORAL" }, { "name": "High patient engagement", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2859, "start_date": "2022-09-13", "completion_date": "2025-09-30", "has_results": true, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-10-05T09:22:26.170Z", "location_count": 3, "location_summary": "Palo Alto, California • West Los Angeles, California • Aurora, Colorado", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "West Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05001009" }, { "nct_id": "NCT04141891", "title": "Advancing Understanding of Transportation Options", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Retinopathy", "Macular Degeneration", "Glaucoma", "Retinitis Pigmentosa", "Vision Disorders", "Acute Coronary Syndrome", "Implantable Defibrillator User", "Congestive Heart Failure", "Hypertrophic Obstructive Cardiomyopathy", "Orthostatic Hypotension", "Syncope", "Presyncope", "Narcolepsy", "Dementia", "Multiple Sclerosis", "Parkinson Disease", "Brain Injuries", "Spinal Cord Injuries", "Stroke", "Vertigo", "Dizziness", "Seizures", "Substance Use", "Insulin Dependent Diabetes Mellitus", "Arthritis", "Foot--Abnormalities", "Chronic Obstructive Pulmonary Disease", "Obstructive Sleep Apnea", "End Stage Renal Disease", "Sleep Apnea", "Insomnia", "Restless Legs Syndrome" ], "interventions": [ { "name": "Driving Decision Aid", "type": "BEHAVIORAL" }, { "name": "Older Drivers Website", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 529, "start_date": "2019-12-12", "completion_date": "2023-12-21", "has_results": true, "last_update_posted_date": "2025-02-21", "last_synced_at": "2026-10-05T09:22:26.170Z", "location_count": 3, "location_summary": "La Jolla, California • Aurora, Colorado • Indianapolis, Indiana", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04141891" }, { "nct_id": "NCT04361552", "title": "Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cerebrovascular Accident", "Chronic Obstructive Pulmonary Disease", "Chronic Renal Failure", "Coronary Artery Disease", "Diabetes Mellitus", "Malignant Neoplasm", "SARS Coronavirus 2 Infection" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Tocilizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2020-04-07", "completion_date": "2020-06-02", "has_results": false, "last_update_posted_date": "2020-06-18", "last_synced_at": "2026-10-05T09:22:26.170Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04361552" }, { "nct_id": "NCT00005485", "title": "The Jackson Heart Study of Cardiovascular Disease Among African Americans", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiovascular Diseases", "Heart Diseases", "Atherosclerosis", "Coronary Disease", "Hypertension", "Cerebrovascular Disorders" ], "interventions": [], "intervention_types": [], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "35 Years to 84 Years" }, "enrollment_count": 5306, "start_date": "2000-09-19", "completion_date": "2025-08-12", "has_results": false, "last_update_posted_date": "2025-07-09", "last_synced_at": "2026-10-05T09:22:26.170Z", "location_count": 1, "location_summary": "Jackson, Mississippi", "locations": [ { "city": "Jackson", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005485" }, { "nct_id": "NCT00122135", "title": "A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Congestive Heart Failure", "Chronic Obstructive Pulmonary Disease", "Cirrhosis", "Colon Carcinoma", "Lung Cancer", "Chronic Kidney Disease" ], "interventions": [ { "name": "Values Inventory (VI)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 120, "start_date": "2004-12", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2015-12-14", "last_synced_at": "2026-10-05T09:22:26.170Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00122135" }, { "nct_id": "NCT01430936", "title": "Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiac Decompensation" ], "interventions": [], "intervention_types": [], "sponsor": "Aventyn, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2011-01", "completion_date": "2012-04", "has_results": false, "last_update_posted_date": "2012-07-10", "last_synced_at": "2026-10-05T09:22:26.170Z", "location_count": 2, "location_summary": "Mineola, New York • Roslyn, New York", "locations": [ { "city": "Mineola", "state": "New York" }, { "city": "Roslyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01430936" } ] }